Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done
Chen Nahshon, Yakir Segev, Meirav Schmidt, Ofer Lavie
Topics & Concepts
MedicineOvarian cancerGynecologyBreast cancerOncologyReduction (mathematics)MutationInternal medicineObstetricsCancerGeneGeneticsGeometryBiologyMathematicsBRCA gene mutations in cancerBreast Cancer Treatment StudiesPARP inhibition in cancer therapy